Ganser A, Carlo-Stella C, Greher J, Völkers B, Hoelzer D
Department of Hematology, University of Frankfurt, FR Germany.
Blood. 1987 Oct;70(4):1173-9.
Interferons (IFNs) have been shown to suppress the proliferation of human pluripotent hematopoietic progenitor cells, CFU-GEMM, and committed erythroid (BFU-E, CFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. However, no information is yet available concerning the effect of IFNs on human megakaryocytic progenitor cells CFU-Mk. Furthermore the mechanisms underlying the inhibitory activity of IFNs are still controversial. Therefore highly purified recombinant IFN preparations, rIFN-alpha and rIFN-gamma, were assessed for their influence on in vitro growth of human bone marrow-derived CFU-Mk as well as CFU-GEMM. In addition, the role of hematopoietic accessory cells, that is, adherent cells and T lymphocytes, in the mediation of the suppressive effect of rIFNs was examined. When added to unseparated bone marrow cells, both rIFN preparations significantly inhibited colony formation with 50% inhibition of CFU-Mk occurring at 22 U/mL for rIFN-alpha and 59 U/mL for rIFN-gamma, while 50% inhibition of CFU-GEMM occurred at 59 U/mL for rIFN-alpha and 101 U/mL for rIFN-gamma. The suppressive effect of rIFN-alpha and rIFN-gamma was selectively abolished by monoclonal antibodies (MoAbs) against rIFN-alpha and rIFN-gamma, thus confirming that the inhibitory activity was due to the rIFN preparations used. The antiproliferative effect of rIFN-alpha and rIFN-gamma on CFU-GEMM growth was not associated with a decrease in the percentage of mixed colonies containing megakaryocytic cells as assessed by use of the MoAb C17.28 against platelet glycoprotein IIIa. Removal of adherent cells and T lymphocytes from the target bone marrow cells had no influence on the suppressive effect of rIFN-alpha, whereas it significantly reduced the inhibitory effect of rIFN-gamma on the growth of megakaryocytic colonies and the other hematopoietic progenitors. The data indicate that (1) human megakaryocytopoiesis is markedly inhibited by rIFN-alpha and rIFN-gamma, and (2) the inhibitory effect of rIFN-alpha is due to a direct action on hematopoietic progenitor cells, whereas the effect of rIFN-gamma is mediated to a significant degree through accessory cell populations.
干扰素(IFNs)已被证明可抑制人多能造血祖细胞、粒-红-巨核-巨噬系集落形成单位(CFU-GEMM)以及定向红系祖细胞(爆式红系集落形成单位BFU-E、红系集落形成单位CFU-E)和粒-巨噬系祖细胞(粒-巨噬系集落形成单位CFU-GM)的增殖。然而,关于干扰素对人巨核系祖细胞CFU-Mk的影响尚无相关信息。此外,干扰素抑制活性的潜在机制仍存在争议。因此,对高纯度重组干扰素制剂,即重组α干扰素(rIFN-α)和重组γ干扰素(rIFN-γ),评估其对人骨髓来源的CFU-Mk以及CFU-GEMM体外生长的影响。此外,还研究了造血辅助细胞,即贴壁细胞和T淋巴细胞,在rIFN抑制作用介导中的作用。当将两种rIFN制剂添加到未分离的骨髓细胞中时,二者均显著抑制集落形成,rIFN-α在22 U/mL时对CFU-Mk的抑制率达50%,rIFN-γ在59 U/mL时达50%;rIFN-α在59 U/mL时对CFU-GEMM的抑制率达50%,rIFN-γ在101 U/mL时达50%。抗rIFN-α和rIFN-γ的单克隆抗体(MoAbs)可选择性消除rIFN-α和rIFN-γ的抑制作用,从而证实抑制活性是由于所使用的rIFN制剂。通过使用抗血小板糖蛋白IIIa的MoAb C17.28评估,rIFN-α和rIFN-γ对CFU-GEMM生长的抗增殖作用与含巨核细胞的混合集落百分比降低无关。从靶骨髓细胞中去除贴壁细胞和T淋巴细胞对rIFN-α的抑制作用没有影响,而它显著降低了rIFN-γ对巨核系集落和其他造血祖细胞生长的抑制作用。数据表明:(1)rIFN-α和rIFN-γ显著抑制人巨核细胞生成;(2)rIFN-α的抑制作用是由于对造血祖细胞的直接作用,而rIFN-γ的作用在很大程度上是通过辅助细胞群体介导的。